NanoMedTrix LLC was founded after over a decade of research. We are developing novel multi-modal contrast agents with cellular tagging capabilities, which have the potential for use as a non-invasive diagnostic tool, as well as in stem cell tracking. They will reduce misdiagnoses, save time and money and reduce patient discomfort while improving patient outcomes. Customers will include doctors, patients, insurers and pre-clinical researchers.